Singapore markets open in 6 hours 33 minutes
  • Straits Times Index

    3,134.66
    +18.34 (+0.59%)
     
  • S&P 500

    4,687.00
    +95.33 (+2.08%)
     
  • Dow

    35,723.65
    +496.62 (+1.41%)
     
  • Nasdaq

    15,695.78
    +470.63 (+3.09%)
     
  • BTC-USD

    51,109.93
    +2,241.28 (+4.59%)
     
  • CMC Crypto 200

    1,316.04
    -5.24 (-0.40%)
     
  • FTSE 100

    7,339.90
    +107.62 (+1.49%)
     
  • Gold

    1,785.30
    +5.80 (+0.33%)
     
  • Crude Oil

    72.36
    +2.87 (+4.13%)
     
  • 10-Yr Bond

    1.4650
    +0.0310 (+2.16%)
     
  • Nikkei

    28,455.60
    +528.23 (+1.89%)
     
  • Hang Seng

    23,983.66
    +634.28 (+2.72%)
     
  • FTSE Bursa Malaysia

    1,497.97
    +14.52 (+0.98%)
     
  • Jakarta Composite Index

    6,602.57
    +55.45 (+0.85%)
     
  • PSE Index

    7,147.30
    +16.56 (+0.23%)
     
AIRLINES:

Omicron’s rapid spread shreds budding recovery in air travel

Why Pfizer and BioNTech Will Be Bigger Winners Than Moderna With Mix-and-Match Boosters

·4-min read
Why Pfizer and BioNTech Will Be Bigger Winners Than Moderna With Mix-and-Match Boosters
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Last week, the U.S. Food and Drug Administration (FDA) authorized the use of "mix-and-match" COVID-19 vaccine boosters. Any person eligible to receive a booster won't have to stick with the same vaccine used in their primary vaccination. This FDA decision opens the door to even more of a contest between the three COVID-19 vaccines currently available in the U.S. That's especially the case between the two most widely adopted vaccines.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting